(4-chloro-2-propyl-1H-imidazol-5-yl)methanol 在
manganese dioxide 二氯甲烷 作用下,
以
二氯甲烷 、 1,4-二氧六环 为溶剂,
反应 6.0h,
以to provide the title compound (0.541 g, 59%) as a pale yellow solid的产率得到2-Propyl-5-Chloroimidazole-4-Carbaldehyde
A process for the production of 2-substituted 5-chlorimidazole-4-carbaldehydes of the general formula: ##STR1## wherein R is hydrogen, an alkyl group, and alkenyl group, a cycloalkyl group, a benzyl group, a phenyl group or an aryl group. These compounds form important intermediate products for the production of antihypertensive pharmaceutical agents or herbicidal compounds.
Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
申请人:——
公开号:US20020143024A1
公开(公告)日:2002-10-03
Novel biphenyl sulfonamide compounds which are combined angiotensin and endothelin receptor antagonists are claimed along with methods of using such compounds in the treatment of conditions such as hypertension and other diseases, as well as pharmaceutical compositions containing such compounds.
[EN] BIPHENYL SULFONAMIDES AS DUAL ANGIOTENSIN ENDOTHELIN RECEPTOR ANTAGONISTS<br/>[FR] BIPHENYL SULFONAMIDES EN TANT QUE DOUBLES ANTAGONISTES DE RECEPTEURS D'ANGIOTENSINE ET D'ENDOTHELINE
申请人:BRISTOL MYERS SQUIBB CO
公开号:WO2000001389A1
公开(公告)日:2000-01-13
Novel biphenyl sulfonamide compounds which are combined angiotensin and endothelin receptor antagonists are claimed along with methods of using such compounds in the treatment of conditions such as hypertension and other diseases, as well as pharmaceutical compositions containing such compounds.
[EN] BIPHENYL SULFONAMIDES AS DUAL ANGIOTENSIN ENDOTHELIN RECEPTOR ANTAGONISTS<br/>[FR] BIPHENYL SULFONAMIDES UTILISES COMME DOUBLES ANTAGONISTES DES RECEPTEURS DE L'ANGIOTENSINE ET DE L'ENDOTHELINE
申请人:BRISTOL MYERS SQUIBB CO
公开号:WO2001044239A2
公开(公告)日:2001-06-21
Novel biphenyl sulfonamide compounds which are combined angiotensin and endothelin receptor antagonists are claimed along with methods of using such compounds in the treatment of conditions such as hypertension and other diseases, as well as pharmaceutical compositions containing such compounds.
Process for the preparation of optionally 2-substituted
申请人:Lonza Ltd.
公开号:US05684157A1
公开(公告)日:1997-11-04
A process for the preparation of 2-substituted 5-chloroimidazole-4-carbaldehydes of the general formula: ##STR1## wherein R is hydrogen, an alkyl group, an alkenyl group, a cycloalkyl group, a benzl group or a phenyl group. The imidazole compounds are important starting products for the preparation of hypotensive pharmaceuticals or herbicides.